Earnings NewsHealthcareVitae Pharmaceuticals EPS in-line, beats on revenueMar. 31, 2015 7:07 AM ETVitae Pharmaceuticals (VTAE) StockBy: Niloofer Shaikh, SA News Editor Vitae Pharmaceuticals (NASDAQ:VTAE): Q4 EPS of -$0.40 in-line. Revenue of $0.16M (-98.9% Y/Y) beats by $0.06M. Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgVTAE--Vitae PharmaceuticalsTrending AnalysisTrending News